Subtype
Intermediate Fibroblastic Neoplasm
CI-CAN-00001015Explore in graph →
Non-malignant31 active trials31 evidence items
- NCIt
- C7333
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001015Explore in graph →
Clinical trials
128 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06526897 | Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma | not yet recruiting | N/A | 1,582 | ECOG-ACRIN Cancer Research GroupNETWORK | 0 | Jul 30, 2024 | clinicaltrials |
| NCT05300893 | Effectiveness of Night Splinting After Percutaneous Needle Fasciotomy in Dupuytren's Contracture | recruiting | N/A | 154 | Uppsala UniversityOTHER | 1 | May 31, 2024 | clinicaltrials |
| NCT03802084 | A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid Tumor | completed | Phase 1 / Phase 2 | 24 | Hyo Song KimOTHER | 1 | May 13, 2024 | clinicaltrials |
| NCT05877066 | Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture(GRASP-DC) | terminated | — | 130 | Endo USA Inc., a Keenova Therapeutics CompanyINDUSTRY | 1 | Apr 16, 2024 | clinicaltrials |
| NCT06355921 | A Prospective Clinical Study on the Safety and Efficacy of Radiofrequency Ablation for the Treatment of Patients With Desmoid Tumors(RFAdesmoid) | not yet recruiting | N/A | 27 | Blokhin's Russian Cancer Research CenterOTHER | 1 | Apr 10, 2024 | clinicaltrials |
| NCT03507010 | Ledderhose Disease: Radiotherapy or Not?(LedRad) | active not recruiting | Phase 3 | 84 | University Medical Center GroningenOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT04229147 | Ledderhose Disease - Long Term Effects of Radiotherapy Treatment. LedRad LTE - Study | completed | — | 68 | University Medical Center GroningenOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT01981551 | Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis | completed | Phase 2 | 17 | National Cancer Institute (NCI)NIH | 1 | Feb 6, 2024 | clinicaltrials |
| NCT06195085 | CT-guided Radioactive Iodine-125 Seed Implantation for Recurrent Desmoid Tumors | completed | — | 38 | Peking University Third HospitalOTHER | 1 | Jan 8, 2024 | clinicaltrials |
| NCT01923103 | Natural Disease Progress of Dupuytren Disease(DD) | completed | — | 261 | University Medical Center GroningenOTHER | 1 | Dec 5, 2023 | clinicaltrials |
| NCT06113094 | Cryoablation for Advanced and Refractory Desmoid Tumors(CARDT) | unknown | — | 30 | University Hospital, Strasbourg, FranceOTHER | 1 | Nov 2, 2023 | clinicaltrials |
| NCT03741764 | Treatment of Dupuytren's Disease With Minimal Invasive Surgery and VIVOSORB® Resorbable Implant Device(Vivosorb) | unknown | N/A | 20 | prof. dr. Ilse DegreefOTHER | 1 | Oct 11, 2023 | clinicaltrials |
| NCT00928525 | Imatinib in Patients With Desmoid Tumor and Chondrosarcoma(Basket 1) | completed | Phase 2 | 35 | Italian Sarcoma GroupNETWORK | 1 | Oct 5, 2023 | clinicaltrials |
| NCT00919269 | Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma | completed | — | 150 | Children's Oncology GroupNETWORK | 7 | Oct 3, 2023 | clinicaltrials |
| NCT04289077 | Quality of Life of Patients With Desmoid-type Fibromatosis(QUALIFIED) | completed | — | 156 | Erasmus Medical CenterOTHER | 2 | Sep 7, 2023 | clinicaltrials |
| NCT01265030 | A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis | completed | Phase 1 / Phase 2 | 9 | MaineHealthOTHER | 1 | Jun 26, 2023 | clinicaltrials |
| NCT05440240 | Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture | recruiting | Phase 4 | 400 | Regionshospitalet SilkeborgOTHER | 1 | May 17, 2023 | clinicaltrials |
| NCT03459469 | Phase I, Open-label, Non-randomized Study to Evaluate Safety of BC2059 | completed | Phase 1 | 24 | Iterion TherapeuticsINDUSTRY | 2 | Mar 1, 2023 | clinicaltrials |
| NCT05561036 | A Randomized, Double-blind,Phase Ⅲ Study of Liposome Doxorubicin in Desmoid Tumor | unknown | Phase 3 | 72 | Sun Yat-sen UniversityOTHER | 1 | Sep 30, 2022 | clinicaltrials |
| NCT00346164 | Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma | completed | Phase 3 | 588 | Children's Oncology GroupNETWORK | 5 | Apr 28, 2022 | clinicaltrials |
| NCT02647619 | Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF | completed | Phase 4 | 80 | University Hospital, AkershusOTHER | 1 | Apr 26, 2022 | clinicaltrials |
| NCT03966742 | Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis | completed | Phase 2 | 8 | Rabin Medical CenterOTHER | 1 | Mar 25, 2022 | clinicaltrials |
| NCT02983162 | Is wGRS Associated With DD Recurrence? | completed | — | 427 | University Medical Center GroningenOTHER | 1 | Feb 10, 2022 | clinicaltrials |
| NCT03031080 | BOND Study: the Benefit Of Night Splinting in Dupuytrens'(BOND) | withdrawn | N/A | 0 | Liverpool University Hospitals NHS Foundation TrustOTHER_GOV | 1 | Sep 27, 2021 | clinicaltrials |
| NCT04907812 | The Role of Tranexamic Acid in Reducing Post Operative Hand Edema After Hand and Wrist Surgery(THAW) | unknown | Phase 4 | 50 | Ruby GrewalOTHER | 1 | Jun 1, 2021 | clinicaltrials |
| NCT03381846 | Treatment of Dermatofibrosarcoma Protuberans in Patients 10 Years and Younger | completed | N/A | 7 | Mayo ClinicOTHER | 1 | Aug 5, 2020 | clinicaltrials |
| NCT02310503 | Spanish Registry of Mohs Surgery(REGESMOHS) | completed | — | 6,000 | Fundación Academia Española de DermatologíaOTHER | 1 | May 5, 2020 | clinicaltrials |
| NCT03331926 | Collagenase is a Common Treatment of MCP and PIP Joint Contractures in Dupuytrens Disease | completed | — | 199 | Jeppe LangeOTHER | 0 | Apr 22, 2020 | clinicaltrials |
| NCT00068419 | Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor | completed | Phase 2 | 70 | Children's Oncology GroupNETWORK | 1 | Feb 19, 2020 | clinicaltrials |
| NCT01962103 | Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors | completed | Phase 1 / Phase 2 | 107 | CelgeneINDUSTRY | 7 | Dec 27, 2019 | clinicaltrials |
| NCT02465528 | Ceritinib Rare Indications Study in ALK+ Tumors | terminated | Phase 2 | 22 | Novartis PharmaceuticalsINDUSTRY | 8 | Dec 27, 2019 | clinicaltrials |
| NCT03868449 | Question Prompt List for Common Hand Conditions | completed | N/A | 126 | Stanford UniversityOTHER | 1 | Oct 16, 2019 | clinicaltrials |
| NCT02374931 | 18F-FES PET/CT in Imaging Patients With Desmoid Tumors | terminated | Early Phase 1 | 3 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Oct 3, 2019 | clinicaltrials |
| NCT03111186 | Ibuprofen Plus Acetaminophen Versus Oxycodone Alone After Hand Surgery | completed | Phase 2 | 40 | University of Southern CaliforniaOTHER | 1 | Sep 26, 2019 | clinicaltrials |
| NCT03982719 | Comparing the Effectiveness of Two Post-fasciectomy Rehabilitation Protocols in Patients With Dupuytren's Disease | unknown | N/A | 40 | Véronique FlamandOTHER | 1 | Jun 13, 2019 | clinicaltrials |
| NCT03874273 | Study of Crizotinib in Children and Adolescents With Myofibroblastic Tumors | unknown | Phase 2 / Phase 3 | 25 | Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyOTHER | 1 | Mar 14, 2019 | clinicaltrials |
| NCT02955446 | Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor Malignancies | no longer available | — | — | University of Colorado, DenverOTHER | 1 | Feb 1, 2019 | clinicaltrials |
| NCT01154452 | Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma | completed | Phase 1 / Phase 2 | 78 | National Cancer Institute (NCI)NIH | 1 | Aug 15, 2018 | clinicaltrials |
| NCT00659360 | AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma | completed | Phase 2 | 17 | National Cancer Institute (NCI)NIH | 2 | Jun 29, 2018 | clinicaltrials |
| NCT03573765 | Epidemiology and Outcomes of Upper Limb Surgery: Analysis of Routine Data | completed | — | 8,308,821 | University of OxfordOTHER | 0 | Jun 29, 2018 | clinicaltrials |
| NCT00528606 | AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Dupuytren's Contracture(CORD-I) | completed | Phase 3 | 308 | Endo USA Inc., a Keenova Therapeutics CompanyINDUSTRY | 1 | Dec 2, 2017 | clinicaltrials |
| NCT01444729 | Post Approval Commitment Study | completed | — | 305 | Endo USA Inc., a Keenova Therapeutics CompanyINDUSTRY | 2 | Oct 26, 2017 | clinicaltrials |
| NCT00528931 | A Pharmacokinetic Study of AA4500 (XIAFLEX™, Proposed Name) in Subjects With Dupuytren's Contracture | completed | Phase 1 | 16 | Endo USA Inc., a Keenova Therapeutics CompanyINDUSTRY | 1 | Oct 5, 2017 | clinicaltrials |
| NCT01407068 | Administration of Two Injections for Multiple Dupuytren's Contractures | completed | Phase 3 | 60 | Endo USA Inc., a Keenova Therapeutics CompanyINDUSTRY | 2 | Oct 5, 2017 | clinicaltrials |
| NCT01674634 | Safety and Efficacy of Two Concurrent Injections of AA4500 in Adult Subjects With Multiple Dupuytren's Contractures | completed | Phase 3 | 715 | Endo USA Inc., a Keenova Therapeutics CompanyINDUSTRY | 1 | Oct 5, 2017 | clinicaltrials |
| NCT03085186 | Treatment With Crizotinib Single Patient Expanded Access IND 134375 | no longer available | — | — | Jean M. Tersak, M.D.OTHER | 0 | Aug 29, 2017 | clinicaltrials |
| NCT01137916 | Study to Evaluate Imatinib in Desmoid Tumors | completed | Phase 2 | 39 | Heidelberg UniversityOTHER | 1 | May 3, 2017 | clinicaltrials |
| NCT00978146 | Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors | withdrawn | Phase 2 | 0 | Children's Hospital of PhiladelphiaOTHER | 0 | Apr 20, 2017 | clinicaltrials |
| NCT01588353 | Collagenase Option for Reduction of Dupuytren's Contracture in Japan(CORD-J) | completed | Phase 3 | 104 | Asahi Kasei Therapeutics CorporationINDUSTRY | 1 | Mar 21, 2017 | clinicaltrials |
Data updated 22 days agoSource updated Jul 30, 2024source: clinicaltrials